Abstract
Background The shortage of chemical reagents for severe acute respiratory syndrome - coronavirus 2 (SARS-CoV-2) diagnosis and the surge of SARS-CoV-2 cases, especially in limited resource settings. Therefore, the combination of an optimal assay kit is necessary.
Methods We compared the ability to screen SARS-CoV-2 among three primer-probe sets added into two different master mixes (Invitrogen™ SuperScript™ III One-Step RT-PCR, and LightCycler Multiplex RNA Virus Master).
Results The assay with TIB-Molbiol, IDT, and Phu Sa sets for LightCycler Multiplex RNA Virus Master or Invitrogen™ SuperScript™ III One-Step RT-PCR showed positive results from a single reaction of triplicate in the three days of 4.8 copies per reaction, with R-square and amplification efficiently (AE) were 0.97 and ranged from 107 to 108%, respectively.
Conclusions Our findings indicated TIB-Molbiol, IDT, and Phu Sa primer-probe sets could be beneficial for the laboratory screening of SARS-CoV-2 by Realtime RT-PCR assay of E gene. There is a need for considering the combination of these reagent sets as a new strategy to increase testing capacity for screening programs for COVID-19.
1. Introduction
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a threat to human health which involves over 7,273,958 confirmed cases and 413,372 deaths [1]. While waiting for the coronavirus vaccine approval, molecular testing for SARS-CoV-2 is one of the important strategies to prevent and reduce the rate of infection by case identification, isolation, social distancing, and proper treatment [2, 3].
Although many factors are leading to the low sensitivity of SARS-CoV-2 such as: a) detection depends on the location of clinical specimens, b) low patient viral load, c) sporadic shedding, and d) discrepancy in detection kits from various producers [4, 5]. However, the molecular diagnosis of SARS-CoV-2 using qRT-PCR assay is a gold standard method [6-8]. Consequently, the combination of an optimal assay kit is necessary because the shortage of chemical reagents for SARS-CoV-2 diagnosis and the surge of SARS-CoV-2 cases, especially in limited-resource settings.
In the present study, we aim to analyze the commonly used primer-probe sets, targeting E gene of SARS-CoV-2 by the Realtime RT-PCR assay for laboratory screening to increase testing capacity in the context of thousands of overseas travelers returning to their countries.
2. MATERIALS AND METHODS
2.1. Primer-probe information
In this study, these three primer-probe sets based on the sequence information received from three different companies, TIB-Molbiol (Berlin, Germany), IDT (Integrated DNA Technologies, Skokie, Illinois, USA) and Phu Sa (Phu Sa Biochem, Vietnam) were used for comparative analysis [8] (Supplementary Table 1).
2.2. Viral preparation
The infection assays were performed in a biosafety level 3 laboratory. Vero E6 cells were infected with a clinical isolate SARS-CoV-2. After 72 hours, the virus medium was collected and heated at 65°C for 1 hour. Viral RNA was then isolated from the culture medium using the QIAamp viral RNA extraction Kit (Qiagen, Hilden, German) following the manufacturer’s instructions. The copy number of RNA extracted from SASR-CoV-2 strain was estimated through a standard curve, which was published in a previous study [9].
2.3. Real-time reverse transcription polymerase chain reaction (RT-PCR) assay confirmation for SARS-CoV-2
RNA extracted specimens from the inactivated virus were tested for comparative assay of SARS-CoV-2 by Real-time RT-PCR on a LightCycle 480 or ABI 7500 system following the manufacturer’s protocol (Invitrogen™ SuperScript™ III One-Step RT-PCR System or LightCycler Multiplex RNA Virus Master). In this study, the reaction combination was made up by multiplying the volumes of each reagent in Table 1.
2.4. Analysis
In this study, Data were entered using Epi-Data version 3.1 (EpiData Association, Odense, Denmark, 2005), and all statistical analysis were performed using Stata version 13.0 (StataCorp, TX, 2013).
The results were summarized using means and standard deviation (SD) for continuous variables. Linear regression analysis was performed to estimate the R-square. Amplification efficiency (AE) was calculated using the equation AE = −1+10(−1/slope) [10].
2.5. Ethical statement
Study protocol has been reviewed and ratified by the Pasteur Institute Ho Chi Minh City Institutional Review Board (reference number: 433/XN-PAS).
3. RESULTS
In this study, the assay with TIB-Molbiol, IDT, and Phu Sa sets for LightCycler Multiplex RNA Virus Master showed positive results from a single reaction of triplicate in the three days of 4.8 copies/reaction (Table 3).
The Ct-values (mean±SD) of E gene (TIB-Mobiol), IDT, and Phu Sa at 1:108 1/2 were 39.02±0.34, 39.17±0.34 and 39.23±0.10, respectively. R2 value from TIB-Mobiol, IDT, and Phu Sa showed equal values of 0.97. Similarly, the AE of each set was also showing the same value, for the figures of TIB-Mobiol and IDT were 107; and Phu Sa was 108 (Table 4).
The assay with TIB-Molbiol, IDT and Phu Sa primer-probe sets for the Invitrogen™ SuperScript™ III One-Step RT-PCR System exhibited positive results from a single reaction of triplicate in the three days of 4.8 copies/reaction (Table 5). Besides the results for LightCycler Multiplex RNA Virus Master, TIB-Molbiol, IDT and Phu Sa sets, they showed the same sensitivity in low concentrations.
In this study, we found that the R-square values from TIB-Molbiol, IDT and Phu Sa were the same (0.97). Similar to the results of LightCycler Multiplex RNA Virus Master, the AE of IDT, and Phu Sa was also the same value (108); and 107 for TIB-Molbiol (Table 6).
4. DISCUSSION
In this study, we reported the comparative analysis of laboratory screening for SARS-CoV-2 among three primer-probe sets added into two different master mixes (Invitrogen™ SuperScript™ III One-Step RT-PCR, and LightCycler Multiplex RNA Virus Master). The initial analysis showed the combination of TIB-Molbiol, IDT, and Phu Sa primer-probe sets were quite sensitive to positive results (4.8 copies/reaction) among Invitrogen™ SuperScript™ III One-Step RT-PCR System (Table 7). In terms of LightCycler Multiplex RNA Virus Master, TIB-Molbiol, IDT, and Phu Sa primer-probe sets also showed the same sensitivity (4.8 copies/reaction). The R-square of each primer-probe set among the different master mixes were around 0.97, which was in agreement with a previous study [11]. Also, the values of AE in each primer-probe set among different master mixes reach the accepted criteria of AE ranged from 90-110%[10].
Our findings found that these primer-probe sets added into two different master mixes were sensitive and reliable for laboratory screening of SARS-CoV-2. Hence, these primer-probe sets could be beneficial for the laboratory screening of SARS-CoV-2 by Real-time RT-PCR assay of E gene. Several previous studies have also shown that the selection of the best primer-probe sets and equipment for SARS-CoV-2 screening and diagnosis were an urgent and important solution for prevention and control COVID-19 [11, 12].
Our findings are partly helpful to improve the capacity of suspected case screenings and to reduce the affected performance of the testing that yield false-negative results [13]. Furthermore, our findings could also contribute to gain better understandings of the combination of the best reagents for SARS-CoV-2 screening to select the most optimum reagents to effectively halt COVID-19.
In the context of the COVID-19 tends to be endemic, the social distancing measure is no longer the ideal solution and while waiting for coronavirus vaccine approval, air travel should return to normal, especially thousands of overseas travelers from the epidemic areas could return to their countries. Therefore, the combination of the reagent sets is essential for screening these subjects. The results of this study are a prelude for other studies to improve the testing capacity of screening suspected cases.
5. CONCLUSION
Our findings indicate TIB-Molbiol, IDT, and Phu Sa primer-probe sets could be beneficial for the laboratory screening of SARS-CoV-2 by Realtime RT-PCR assay of E gene. There is a need for considering the combination of these reagent sets as a new strategy to increase the testing capacity for screening programs for COVID-19.
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
Conflict interest
The authors have no conflicts of interest.
Declaration of Funding
This research received no external funding.
Abbreviation
- RT-PCR
- Reverse transcription polymerase chain reaction
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- Corona virus infected diseases 19
Acknowledgments
We would like to thank colleagues at Pasteur Institute, Ho Chi Minh City for supporting the study. Thanks for Mr. Alan Tan, Sydney, Australia edited and proofread the manuscript.